EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of HLA-A*11:01 and A*02:01-Restricted EBV Peptides Using HLA Peptidomics

Yufei Wang, Wanlin Zhang, Ruona Shi iD, Yanran Luo, Zhenhuan Feng iD, Yanhong Chen, Qiuting Zhang, Yan Zhou, Jingtong Liang, Xiaoping Ye, Qisheng Feng, Xiaofei Zhang iD und 1 weitere

Viruses · 2024

DOI: 10.3390/v16050669 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Yufei Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Cli…. Hauptthemen laut MEDLINE: Herpesvirus 4, Human, HLA-A11 Antigen, HLA-A2 Antigen, Nasopharyngeal Carcinoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China Grant, National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epstein-Barr Virus (EBV) is closely linked to nasopharyngeal carcinoma (NPC), notably prevalent in southern China. Although type II latency of EBV plays a crucial role in the development of NPC, some lytic genes and intermittent reactivation are also critical for viral propagation and tumor progression. Since T cell-mediated immunity is effective in targeted killing of EBV-positive cells, it is important to identify EBV-derived peptides presented by highly prevalent human leukocyte antigen class I (HLA-I) molecules throughout the EBV life cycle. Here, we constructed an EBV-positive NPC cell model to evaluate the presentation of EBV lytic phase peptides on streptavidin-tagged specific HLA-I molecules. Utilizing a mass spectrometry (LC-MS/MS)-based immunopeptidomic approach, we characterized eleven novel EBV peptides as well as two previously identified peptides. Furthermore, we determined these peptides were immunogenic and could stimulate PBMCs from EBV VCA/NA-IgA positive donors in an NPC endemic southern Chinese population. Overall, this work demonstrates that highly prevalent HLA-I-specific EBV peptides can be captured and functionally presented to elicit immune responses in an in vitro model, which provides insight into the epitopes presented during EBV lytic cycle and reactivation. It expands the range of viral targets for potential NPC early diagnosis and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 4, HumanHLA-A11 AntigenHLA-A2 AntigenNasopharyngeal CarcinomaNasopharyngeal NeoplasmsPeptidesHumansCell Line, TumorChinaEpitopes, T-LymphocyteEpstein-Barr Virus InfectionsProteomicsTandem Mass Spectrometry

Stichwörter der Autor:innen

Epstein-Barr VirusHLA peptidomicsepitopesnasopharyngeal carcinoma

Substanzen

Epitopes, T-LymphocyteHLA-A*02:01 antigenHLA-A*11:01 antigenHLA-A11 AntigenHLA-A2 AntigenPeptides

Autor:innen und Institutionen

  • State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center…
  • Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangdong-Hong Kong Joint Laboratory for Stem Cell and Regenerative Medicine, Center for Cell Lineage and Development, Guangzhou Institutes of…
  • Joint School of Life Sciences, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou Medical University, Guangzhou 511436, China.

ORCID-Profile: Ruona Shi, Zhenhuan Feng, Xiaofei Zhang, Miao Xu

Förderung

  • National Key Research and Development Program of China Grant
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Science and Technology Planning Project of Guangdong Province
  • Major Project of Guangzhou National Laboratory
  • Guangdong Pearl River Talents Program

Zitieren

APA

Wang, Y., Zhang, W., Shi, R., Luo, Y., Feng, Z., Chen, Y., Zhang, Q., Zhou, Y., Liang, J., Ye, X., Feng, Q., Zhang, X., & Xu, M. (2024). Identification of HLA-A*11:01 and A*02:01-Restricted EBV Peptides Using HLA Peptidomics. Viruses. https://doi.org/10.3390/v16050669

Vancouver

Wang Y, Zhang W, Shi R, Luo Y, Feng Z, Chen Y, et al. Identification of HLA-A*11:01 and A*02:01-Restricted EBV Peptides Using HLA Peptidomics. Viruses. 2024. doi:10.3390/v16050669

BibTeX
@article{Wang2024,
  author = {Wang, Yufei and Zhang, Wanlin and Shi, Ruona and Luo, Yanran and Feng, Zhenhuan and Chen, Yanhong and Zhang, Qiuting and Zhou, Yan and Liang, Jingtong and Ye, Xiaoping and Feng, Qisheng and Zhang, Xiaofei and Xu, Miao},
  title = {Identification of HLA-A*11:01 and A*02:01-Restricted EBV Peptides Using HLA Peptidomics},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16050669}
}
Kostenlos starten →